Evidence map›Paper›PMID 37569047›Full record

ArticleInternational journal of environmental research and public health2023

Study Protocol for a Hospital-to-Home Transitional Care for Older Adults Hospitalized with Chronic Obstructive Pulmonary Disease in South Korea: A Randomized Controlled Trial.

Heui-Sug Jo, Woo-Jin Kim, Yukyung Park, Yu-Seong Hwang, Seon-Sook Han, Yeon-Jeong Heo, Dahye Moon, Su-Kyoung Kim, Chang-Youl Lee

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in International journal of environmental research and public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Heui-Sug JoDepartment of Health Policy and Management, School of Medicine, Kangwon National University, 1 Kangwondaehak-gil, Chuncheon-si 24341, Republic of Korea.ORCID 0000-0003-0245-3583
Woo-Jin KimDepartment of Internal Medicine, Kangwon National University, 1 Kangwondaehak-gil, Chuncheon-si 24341, Republic of Korea.ORCID 0000-0003-2927-370X
Yukyung ParkDepartment of Preventive Medicine, Kangwon National University Hospital, 156, Baengnyeong-ro, Chuncheon-si 24289, Republic of Korea.
Yu-Seong HwangDepartment of Health Policy and Management, School of Medicine, Kangwon National University, 1 Kangwondaehak-gil, Chuncheon-si 24341, Republic of Korea.ORCID 0000-0001-8934-3533
Seon-Sook HanDepartment of Internal Medicine, Kangwon National University Hospital, 156, Baengnyeong-ro, Chuncheon-si 24289, Republic of Korea.
Yeon-Jeong HeoDepartment of Internal Medicine, Kangwon National University Hospital, 156, Baengnyeong-ro, Chuncheon-si 24289, Republic of Korea.
Dahye MoonDepartment of Internal Medicine, Kangwon National University Hospital, 156, Baengnyeong-ro, Chuncheon-si 24289, Republic of Korea.
Su-Kyoung KimDepartment of Health Policy and Management, School of Medicine, Kangwon National University, 1 Kangwondaehak-gil, Chuncheon-si 24341, Republic of Korea.ORCID 0000-0003-0415-1538
Chang-Youl LeeDivision of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, 77, Sakju-ro, Chuncheon-si 24253, Republic of Korea.ORCID 0000-0002-4088-4993
Kangwon National University · KRKangwon National University Hospital · KRHallym University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition characterized by persistent inflammation in the airways, resulting in narrowing and obstruction of the air passages. The development of COPD is primarily attributed to long-term exposure to irritants, such as cigarette smoke and environmental pollutants. Among individuals hospitalized for exacerbations of COPD, approximately one in five is readmitted within 30 days of discharge or encounters immediate post-discharge complications, highlighting a lack of adequate preparedness for self-management. To address this inadequate preparedness, transitional care services (TCS) have emerged as a promising approach. Therefore, this study primarily aims to present a detailed protocol for a multi-site, single-blind, randomized, controlled trial (RCT) aimed at enhancing self-management competency and overall quality of life for patients with COPD through the provision of TCS, facilitated by a proficient Clinical Research Coordinator. The RCT intervention commenced in September 2022 and is set to conclude in December 2024, with a total of 362 COPD patients anticipated to be enrolled in the study. The intervention program encompasses various components, including an initial assessment during hospitalization, comprehensive self-management education, facilitation of social welfare connections, post-discharge home visits, and regular telephone monitoring. Furthermore, follow-up evaluations are conducted at both one month and three months after discharge to assess the effectiveness of the intervention in terms of preventing re-hospitalization, reducing acute exacerbations, and enhancing disease awareness among participants. The results of this study are expected to provide a basis for the development of TCS fee payment policies for future health insurance.

Indexed as

Pulmonary Disease, Chronic ObstructiveTransitional CareAgedBehavior TherapyHospitalizationHospitalsHumansQuality of LifeRandomized Controlled Trials as Topicchronic obstructive pulmonary diseaseolder adulttransitional care

Identifiers

PMID37569047
PMCPMC10418954
OpenAlexW4385491123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.